PRX-102 for treating Fabry disease: immunogenicity and PK results from a phase 1-2 study

David Warnock, Derralynn Hughes, Simeon Boyd, Pilar Giraldo, Derlis Gonzalez, Myrl Holida, Ozlem Goker-Alpan, Gustavo Maegawa, Mohamed Atta, Kathy Nicholls, Raphael Schiffmann, Ahmad Tuffaha, Martha Charney, Raul Chertkoff, Sari Alon, Einat Brill-Almon
  • Molecular Genetics and Metabolism, January 2017, Elsevier
  • DOI: 10.1016/j.ymgme.2016.11.364

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.ymgme.2016.11.364

The following have contributed to this page: Mr Myrl D. Holida